kawasaki
diseas
kd
one
common
caus
vascul
affect
children
although
inflammatori
respons
found
medium
small
vessel
throughout
bodi
common
site
damag
coronari
arteri
make
kd
lead
caus
acquir
heart
diseas
children
develop
world
kd
continu
diagnost
challeng
singl
diagnost
test
uniqu
clinic
find
distinguish
kd
acut
febril
exanthem
childhood
although
call
diseas
kd
truli
syndrom
complex
character
multisystem
inflamm
kd
present
clinic
prolong
fever
usual
greater
day
durat
polymorph
skin
rash
nonexud
bilater
conjunctiv
inject
oral
mucos
inflamm
erythema
lip
strawberri
tongu
extrem
chang
includ
red
palm
sole
swell
dorsum
hand
feet
well
cervic
lymphadenopathi
typic
unilater
greater
cm
diamet
presenc
fever
plu
least
four
five
princip
featur
constitut
diagnosi
typic
kd
tabl
absenc
specif
diagnost
test
diseas
continu
hinder
identif
affect
children
lack
predict
marker
clinic
heterogen
clinic
syndrom
obstacl
improv
therapi
affect
children
common
age
occurr
month
year
although
younger
children
adult
affect
sinc
initi
clinic
descript
japan
hawaii
number
case
kd
increas
dramat
current
recogn
worldwid
kd
seen
ethnic
group
region
world
incid
diseas
vari
dramat
region
region
differ
ethnic
group
suggest
major
role
genet
kd
risk
outcom
annual
incid
report
number
per
children
year
age
rang
denmark
new
zealand
canada
hong
kong
china
korea
japan
sibl
affect
children
tenfold
higher
risk
kd
compar
gener
popul
incid
kd
twofold
higher
normal
children
affect
individu
asia
north
america
kd
common
winter
earli
spring
month
boy
outnumb
girl
greater
three
quarter
affect
children
age
case
fatal
rate
kd
japan
number
appear
decreas
recent
nationwid
survey
done
countri
activ
surveil
program
kd
virtual
death
patient
kd
result
cardiac
sequela
peak
mortal
report
occur
day
onset
fever
subacut
phase
ill
inflamm
continu
coupl
mark
elev
platelet
count
hypercoagul
state
sudden
death
myocardi
infarct
may
also
occur
year
acut
kd
episod
children
coronari
arteri
aneurysm
stenosi
despit
numer
studi
etiolog
kd
remain
elus
kd
link
mani
differ
etiolog
agent
rang
bacteria
staphylococcu
streptococcu
proprionibacterium
chalmydia
virus
epsteinbarr
viru
parvoviru
coronaviru
retrovirus
one
caus
agent
consist
demonstr
kd
fit
nice
spectrum
infecti
diseas
inflammatori
syndrom
true
autoimmun
diseas
infecti
trigger
lead
prolong
selfdirect
immun
respons
genet
suscept
host
etiolog
debat
center
around
mechan
immun
activ
convent
antigen
versu
superantigen
evid
support
hypothes
continu
accumul
investig
focus
work
identifi
one
specif
pathogen
famili
pathogen
respons
diseas
one
group
identifi
oligoclon
iga
antibodi
present
arteri
tissu
fatal
case
kd
recent
interest
debat
center
novel
human
coronaviru
found
group
investig
respiratori
secret
children
kd
other
investig
abl
confirm
data
echo
outbreakdepend
natur
syndrom
longer
search
singl
infecti
agent
longer
list
divers
infecti
organ
found
presenc
share
properti
common
multipl
infecti
agent
result
pathogen
process
lead
clinic
syndrom
kd
anoth
explan
one
common
featur
mani
infecti
organ
presenc
superantigen
activ
superantigen
group
protein
share
abil
stimul
larg
proport
cell
cell
repertoir
compar
one
million
cell
convent
antigen
bind
portion
tcell
receptor
b
chain
tcrvb
associ
major
histocompat
complex
mhc
class
ii
molecul
requir
antigen
process
superantigen
identifi
varieti
microorgan
includ
bacteria
staphylococci
streptococci
mycobacterium
mycoplasma
yersinia
virus
rabi
ebv
evid
number
kd
outbreak
point
classic
footprint
superantigen
specif
tcrvb
skew
peripher
blood
affect
cardiac
tissu
although
debat
continu
regard
mechan
initi
immun
activ
like
scenario
cooper
differ
mechan
final
common
pathway
immun
activ
respons
clinic
syndrom
one
unifi
featur
kd
prolong
inflammatori
respons
possibl
mani
case
infecti
trigger
start
inflammatori
process
elimin
children
develop
kd
persist
inflammatori
respons
becom
problem
contain
inflammatori
respons
one
object
therapi
acut
kd
inflamm
worrisom
prolong
inflamm
lead
activ
downstream
effector
lead
coronari
arteri
damag
system
inflamm
strike
find
kd
evidenc
clinic
biochem
acut
phase
ill
like
syndrom
character
system
inflamm
tnfa
markedli
elev
children
acut
phase
kd
tnfa
pleiotrop
cytokin
critic
regul
immun
cell
play
critic
role
inflamm
link
system
immun
respons
seen
acut
phase
kd
subsequ
damag
coronari
arteri
clearli
understood
emerg
evid
tnfa
critic
pathogenesi
kd
specif
level
target
tissueth
coronari
arteri
key
downstream
effect
tnfa
signal
includ
leukocyt
recruit
coronari
arteri
upregul
matrix
degrad
enzym
proinflammatori
cytokin
tnfa
upregul
express
activ
mani
member
matrix
metalloproteinas
mmp
famili
enzym
mmp
famili
zincdepend
matrixdegrad
proteas
share
abil
degrad
molecul
extracellular
matrix
elastin
import
extracellular
matrix
compon
arteri
vessel
wall
breakdown
elastin
lead
loss
structur
integr
vessel
wall
balloon
hallmark
aneurysm
format
mmp
play
import
role
degrad
elastin
lead
aneurysm
format
two
mmp
particular
local
area
inflamm
intern
elast
lamina
degrad
aneurysm
fatal
case
human
kd
express
coronari
arteri
aneurysm
nonkd
control
coronari
vessel
suggest
role
develop
aneurysm
kd
mani
featur
suggest
infecti
trigger
ill
endem
season
fluctuat
punctuat
epidem
outbreak
mani
clinic
featur
kd
outbreak
depend
differ
spectrum
clinic
find
found
one
mini
outbreak
anoth
case
similar
clinic
phenotyp
cluster
tempor
kd
divid
three
phase
acut
subacut
convalesc
acut
phase
character
multisystem
vascul
evidenc
classic
sign
inflamm
includ
red
heat
swell
five
princip
featur
plu
fever
distinct
inflammatori
chang
seen
ill
mani
associ
clinic
featur
attribut
underli
vascul
effect
kd
multipl
system
bodi
well
recogn
includ
asept
mening
anterior
uveiti
myositi
hydrop
gall
bladder
pattern
manifest
mani
associ
featur
evolv
past
decad
mainli
due
chang
pattern
clinic
treatment
arthriti
also
common
find
kd
seen
children
diagnosi
kd
compar
favor
much
higher
incid
preintraven
immunoglobulin
ivig
treatment
era
arthriti
acut
kd
effus
often
note
intens
pain
affect
ambul
mani
instanc
predomin
larg
joint
affect
regardless
pattern
joint
involv
clinic
cours
symptomat
arthriti
shortliv
major
affect
children
affect
children
dramat
rapid
resolut
arthriti
follow
combin
treatment
ivig
high
dose
aspirin
regardless
number
joint
involv
distribut
diseas
despit
evid
increas
system
inflamm
children
arthriti
respons
treatment
coronari
outcom
unchang
compar
children
without
arthriti
subacut
phase
ill
character
resolut
fever
well
associ
system
symptom
associ
inflamm
often
classic
peel
skin
start
periungu
region
finger
toe
phase
coronari
arteri
lesion
commonli
detect
despit
earli
treatment
high
dose
ivig
aspirin
aneurysm
continu
develop
approxim
children
appropri
treat
adjust
bodi
surfac
area
number
increas
affect
children
develop
coronari
arteri
lesion
cal
kd
recogn
number
one
caus
acquir
heart
diseas
children
develop
world
increas
recognit
typic
kd
see
tabl
differenti
diagnosi
challeng
clinic
recognit
children
present
incomplet
atyp
diseas
incomplet
kd
appropri
term
children
present
atyp
featur
rather
simpli
present
full
clinic
pictur
typic
diseas
fever
less
four
five
princip
clinic
featur
kd
diagnosi
kd
strictli
base
clinic
criteria
said
mani
physician
expert
area
recogn
support
criteria
aid
identif
group
children
increas
risk
develop
cal
american
heart
associ
aha
propos
algorithm
aid
evalu
manag
children
fulfil
full
diagnost
criteria
kd
fig
propos
support
criteria
includ
laboratori
find
reflect
underli
multisystem
inflamm
includ
elev
creactiv
protein
crp
rais
erythrocyt
sediment
rate
esr
hypoalbuminemia
anemia
elev
serum
transaminas
thrombocytosi
leukocytosi
tabl
incomplet
kd
present
clinician
challeng
correctli
identifi
treat
patient
prevent
develop
coronari
arteri
lesion
studi
investig
contribut
clinic
phenotyp
coronari
outcom
identifi
durat
fever
power
predictor
poor
coronari
outcom
durat
fever
may
indirect
measur
sever
underli
vascul
surrog
marker
inflamm
includ
platelet
count
serum
albumin
level
failur
respond
ivig
therapi
relat
fever
durat
clinic
laboratori
featur
identifi
highrisk
factor
develop
coronari
arteri
aneurysm
take
home
messag
evalu
manag
child
suspect
kd
high
index
suspicion
kd
children
present
prolong
fever
everi
young
child
prolong
fever
sign
symptom
consist
kd
diseas
account
clinic
find
need
close
clinic
followup
appropri
laboratori
investig
fig
aha
algorithm
aim
improv
identif
risk
children
initi
appropri
treatment
affect
children
basic
patholog
lesion
kd
necrot
vascul
fibrinoid
necrosi
mediums
muscular
arteri
predominantli
coronari
arteri
venou
involv
also
document
initi
lesion
begin
figur
propos
algorithm
american
heart
associ
evalu
child
suspect
kawasaki
diseas
adapt
newburg
microcircul
adventitia
inflammatori
cell
detect
day
fever
onset
neutrophil
rapidli
give
way
lymphocyt
larg
mononuclear
cell
destruct
extern
elast
lamina
layer
arteri
accompani
cellular
infiltr
result
aneurysm
format
major
longterm
sequela
kd
damag
coronari
vasculatur
thu
cardiac
imag
integr
compon
manag
children
kd
twodimension
echocardiographi
imag
modal
choic
due
noninvas
natur
high
sensit
specif
detect
abnorm
proxim
segment
coronari
arteri
echocardiograph
evalu
coronari
anatomi
includ
assess
intern
coronari
arteri
diamet
number
locat
aneurysm
absenc
presenc
intralumin
thrombu
also
assess
criteria
use
defin
coronari
arteri
abnorm
kd
first
propos
japanes
ministri
health
criteria
applic
either
angiograph
echocardiograph
measur
defin
coronari
arteri
abnorm
intern
lumen
diamet
greater
mm
children
less
year
age
greater
mm
children
year
age
intern
diamet
segment
measur
least
time
adjac
segment
coronari
arteri
lumen
clearli
irregular
tabl
aha
classifi
aneurysm
small
mm
medium
mm
giant
mm
coronari
arteri
dimens
normal
children
increas
linearli
bodi
size
measur
bodi
surfac
area
bsa
thu
recent
investig
recogn
need
correct
bsa
classifi
coronari
arteri
lesion
measur
greater
standard
deviat
expect
mean
use
correct
bsa
definit
zscore
approxim
incid
cal
despit
appropri
treatment
although
coronari
anatomi
focu
attent
kd
cardiac
function
includ
imag
evalu
depress
ventricular
contractil
common
earli
acut
kd
histolog
studi
suggest
myocard
univers
acut
phase
although
imag
protocol
may
vari
agre
uncompl
case
echocardiograph
evalu
need
time
diagnosi
subacut
phase
week
addit
echo
time
point
may
need
guid
manag
highrisk
patient
advoc
repeat
imag
month
year
post
acut
kd
recent
studi
suggest
normal
coronari
outcom
subacut
echo
unlik
chang
year
remain
limit
echocardiographi
includ
detect
thrombi
coronari
arteri
stenosi
addit
visual
coronari
arteri
becom
difficult
child
grow
bodi
size
increas
angiographi
intravascular
ultrasound
transesophag
echocardiographi
magnet
reson
angiographi
ultrafast
comput
tomographi
may
benefit
manag
certain
case
initi
size
aneurysm
import
contributor
likelihood
resolutionregress
lesion
smaller
aneurysm
like
regress
coronari
aneurysm
regress
may
progress
stenosi
occlus
abnorm
tortuos
show
continu
aneurysm
morpholog
aneurysm
dilat
also
progress
ruptur
fortun
extrem
rare
kd
high
dose
ivig
accept
therapi
acut
kd
efficaci
reduc
preval
coronari
arteri
follow
three
condit
bsa
normal
zscore
lad
rca
japanes
ministri
health
definit
coronari
arteri
aneurysm
includ
coronari
arteri
intern
diamet
mm
year
old
coronari
arteri
intern
diamet
mm
year
old
coronari
arteri
intern
diamet
time
adjac
segment
coronari
arteri
lumen
clearli
irregular
suggest
featur
includ
perivascular
bright
lesion
well
document
mani
differ
dose
administr
schedul
use
north
america
europ
japan
gener
consensu
higher
dose
given
singl
infus
greatest
efficaci
sever
metaanalysi
confirm
dose
effect
dose
comparison
studi
show
signific
reduct
aneurysm
increas
dose
receiv
gkg
singl
dose
show
reduct
number
aneurysm
well
reduct
durat
fever
compar
receiv
lower
dose
differ
predict
instrument
develop
model
risk
poor
coronari
outcom
japan
harada
score
develop
aid
ration
alloc
limit
ivig
suppli
highest
risk
aneurysm
format
addit
clinic
factor
alreadi
describ
male
sex
young
month
old
ad
demograph
featur
risk
aha
recommend
ivig
administ
singl
infus
dose
gkg
infus
protocol
start
slow
rate
stepwis
increas
infus
rate
total
durat
ivig
infus
typic
h
depend
concentr
ivig
multisystem
inflamm
involv
heart
potenti
compromis
heart
abil
handl
fluid
challeng
associ
ivig
infus
thu
necessit
long
durat
infus
ivig
therapi
institut
acut
phase
ill
typic
within
first
day
fever
ivig
treatment
indic
anytim
acut
phase
ill
even
present
day
ill
earli
treatment
ivig
day
ill
affect
coronari
outcom
may
increas
need
ivig
retreat
observ
may
bias
sever
phenotyp
treat
earli
analyz
separ
treat
earli
day
fever
higher
risk
score
treat
later
suggest
treat
earli
diseas
cours
dramat
clinic
featur
impli
intens
inflamm
sever
vascul
ivig
made
pool
donor
plasma
manufactur
product
differ
present
ongo
conflict
investig
potenti
differ
efficaci
sideeffect
profil
differ
ivig
prepar
nonetheless
prescrib
practic
vari
institut
institut
use
mani
differ
product
concentr
solut
ivig
employ
acut
therapi
kd
may
dictat
product
avail
although
mechan
action
ivig
treatment
kd
clearli
understood
ivig
gener
immunomodulatori
effect
possibl
mechan
action
includ
gener
immunosuppress
via
modul
proinflammatori
cytokin
product
regul
express
function
fc
receptor
inhibit
activ
complement
neutral
bacteri
superantigen
infecti
agent
antiidiotyp
antibodi
effect
effect
activ
differenti
effector
function
cell
b
cell
antigen
present
cell
due
protect
effect
receiv
pool
immunoglobulin
gener
immunomodulatori
effect
immun
may
gener
effect
protect
immun
respons
month
ivig
administr
although
harmless
receiv
immun
live
kill
vaccin
may
effect
child
may
need
reimmun
month
ivig
administr
inadequ
immun
respons
typic
live
vaccin
defer
month
child
receiv
high
dose
ivig
unless
risk
infecti
exposur
high
wide
debat
issu
acut
therapi
kd
dose
aspirin
high
versu
low
dose
high
dose
aspirin
import
antiinflammatori
properti
low
dose
antiplatelet
activ
high
dose
salicyl
inhibit
activ
ikk
therebi
prevent
nfkb
nuclear
transloc
lower
dose
salicyl
inhibit
cyclooxygenas
enzym
lead
reduct
prostaglandin
thromboxan
synthesi
despit
high
dose
aspirin
addit
mechan
immunomodul
compar
low
dose
aspirin
inhibit
nuclear
transloc
nfkb
affect
transcript
regul
import
proinflammatori
cytokin
well
inhibit
tnfa
signal
transduct
administr
aspirin
acut
phase
kd
appear
alter
coronari
outcom
acut
phase
kd
antiinflammatori
dose
aspirin
mgkgday
given
four
divid
dose
typic
prescrib
north
america
circul
total
salicyl
level
shown
vari
tremend
despit
consist
oral
dose
mgkgday
serum
concentr
rang
mgml
durat
high
dose
aspirin
therapi
vari
institut
institut
mani
center
reduc
aspirin
dose
antiplatelet
level
mgkgday
affect
child
afebril
h
other
continu
antiinflammatori
dose
aspirin
day
ill
longer
japan
dose
aspirin
use
lower
mgkg
may
reflect
differ
pharmacokinet
aspirin
metabol
orient
popul
cochran
review
aspirin
therapeut
manag
acut
phase
kd
conclud
insuffici
evid
support
refut
use
aspirin
part
treatment
regimen
due
lack
good
qualiti
random
clinic
trial
low
dose
aspirin
administ
antiplatelet
effect
typic
continu
child
show
evid
coronari
arteri
damag
week
fever
onset
laboratori
measur
inflamm
return
normal
children
coronari
arteri
lesion
may
continu
aspirin
antiplatelet
agent
indefinit
one
major
challeng
current
manag
kd
treatment
patient
fail
respond
initi
therapi
ivig
ten
twenti
percent
children
respond
singl
dose
ivig
definit
refractori
diseas
treatment
failur
vari
gener
defin
persist
recrudesc
fever
h
initi
ivig
therapi
persist
fever
common
recrudesc
fever
although
debat
continu
regard
optim
therapi
refractori
diseas
investig
agre
second
dose
ivig
second
dose
ivig
continu
high
dose
therapi
gkg
treatment
subgroup
patient
refractori
kd
includ
addit
ivig
corticosteroid
much
less
commonli
variou
immunosuppress
agent
includ
cyclophosphamid
cyclosporin
well
plasma
exchang
inhibit
elastas
activ
ulinastatin
recent
biolog
therapi
tumor
necrosi
factoralpha
fig
goal
therapi
amelior
immun
respons
thu
decreas
chanc
ongo
inflamm
damag
coronari
arteri
order
therapeut
intervent
continu
controversi
although
steroid
efficaci
wide
use
form
vascul
use
kd
limit
use
steroid
acut
kd
controversi
recent
studi
shown
use
acut
phase
well
refractori
diseas
kd
refractori
ivig
common
indic
corticosteroid
use
patient
kd
treatment
found
effect
rapid
resolut
fever
major
patient
common
dose
regimen
steroid
high
dose
puls
steroid
given
intraven
methylprednisolon
mgkg
maximum
g
given
per
day
day
dose
regimen
vari
center
center
littl
evid
avail
support
dose
schedul
steroid
administr
institut
high
dose
iv
dose
may
follow
oral
prednison
mgkgday
rapidli
taper
cours
week
unless
resist
fever
fever
recrudesc
requir
longer
taper
altern
therapi
fig
prospect
studi
avail
guid
treatment
decis
children
coronari
arteri
lesion
thu
recommend
base
knowledg
pathophysiolog
lesson
learn
adult
coronari
diseas
basi
therapeut
guidelin
prevent
thrombosi
specif
manag
depend
extent
sever
coronari
arteri
diseas
antiplatelet
therapi
alon
combin
anticoagul
integr
compon
manag
plan
thrombocytosi
togeth
platelet
activ
key
find
kd
thu
necessit
use
antiplatelet
agent
low
dose
aspirin
use
even
evid
coronari
damag
followup
echocardiogram
may
continu
indefinit
coronari
arteri
damag
presenc
sever
coronari
diseas
addit
anoth
antiplatelet
agent
target
nonasadepend
pathway
platelet
activ
dipyridamol
clopidogrel
may
includ
presenc
larg
giant
aneurysm
pose
signific
thrombot
risk
anticoagul
ad
acut
phase
usual
choic
heparin
longterm
anticoagul
achiev
either
warfarin
lowmolecular
weight
heparin
combin
antiplatelet
agent
littl
data
avail
guid
intervent
presenc
intravascular
thrombi
recent
trial
target
platelet
glycoprotein
iibiiia
receptor
involv
final
common
pathway
platelet
aggreg
abciximab
platelet
glycoprotein
iibiiia
receptor
inhibitor
use
acut
children
intralumin
thrombu
reestablish
vessel
patenc
salvag
myocardium
summari
kd
import
caus
acquir
heart
diseas
childhood
increas
recognit
typic
kd
challeng
clinic
recognit
children
present
incomplet
clinic
present
high
index
suspicion
everi
child
prolong
fever
sign
symptom
consist
kd
coupl
close
clinic
followup
appropri
laboratori
investig
imag
warrant
prolong
inflamm
lead
coronari
arteri
damag
underli
patholog
kd
earli
identif
treatment
affect
children
suppress
inflammatori
respons
one
object
therapi
high
dose
ivig
togeth
aspirin
mainstay
therapi
acut
kd
diseas
model
continu
imperfect
futur
studi
need
identifi
novel
biomark
enhanc
tradit
clinic
laboratori
measur
inflamm
ultim
goal
identif
highrisk
phenotyp
guid
clinic
decis
involv
use
therapeut
intervent
improv
coronari
outcom
affect
children
